This page is the continuation of references in support of Section 6H
REFERENCES
Alizadeh, A.A., Ross, D.T., Perou, C.M., van de Rijn, M. (2001). Towards a novel classification of human malignancies based on gene expression patterns. J. Pathol 195, 41–52. (Retrieved 19th Feb 2015): http://onlinelibrary.wiley.com/doi/10.1002/path.889/abstract;jsessionid=9863A22FF62CA10EE7AE6EC1F456D211.f04t04
Alphy RJ, Sreelekha TT. (2012) Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer. Lung Cancer International: Article ID 729532 (Retrieved 19th Feb 2015): http://www.hindawi.com/journals/lci/2012/729532/
Awad MM, Shaw AT.(2014) ALK Inhibitors in Non–Small Cell Lung Cancer: Crizotinib and Beyond. Clin Adv Hematol Oncol. Jul; 12(7): 429–439. (Retrieved 29th April 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215402/
Brambilla E, Travis WD, Colby TV et al. (2001). The new World Health Organization classification of lung tumours. Eur Respir J 18, 1059–1068. (Retrieved 5th Feb 2015): ttp://erj.ersjournals.com/content/18/6/1059.long
Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV. et al. (2002) p63 Expression Profiles in Human Normal and Tumor Tissues. Clin Cancer Res February 8;494 (Retrieved 28th April 2015): https://www.ncbi.nlm.nih.gov/pubmed/11839669
Langer CJ, Stephenson P, Thor A, Vangel M, Johnson DH; Eastern Cooperative Oncology Group Study 2598. (2004) Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group study 2598. J Clin Oncol: Apr 1;22(7):1180-7. Epub 2004 Feb 23. (Retrieved 29th April 2015): http://www.ncbi.nlm.nih.gov/pubmed/14981103
O’Connor C, (2001). Fluorescence In Situ Hybridization (FISH). Nature Education 1(1):171 (Retrieved 29th April 2015): http://www.nature.com/scitable/topicpage/fluorescence-in-situ-hybridization-fish-327
Weinstein IB. (2002). Addiction to oncogenes: the Achilles heel of cancer. Science 297 63–64. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/12098689
